Celadon Pharmaceuticals 2023 Cannabis-Based Medicines Investor Presentation

Celadon Pharmaceuticals is a UK-listed pharmaceutical company developing cannabis-based medicines, operating a 100,000 sq ft hydroponic production facility with over £65m replacement value. The company has secured letters of intent from customers, launched a pain trial targeting NHS reimbursement, and maintains a pipeline of targeted therapies seeking regulatory approvals.